These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7210369)

  • 41. In vivo models of human prostate cancer bone metastasis.
    Brown JM
    Methods Mol Med; 2003; 81():149-62. PubMed ID: 12725119
    [No Abstract]   [Full Text] [Related]  

  • 42. Prostate carcinoma metastasis to the mandible: report of a case.
    Laski R; Ziccardi VB; Najjar T
    J N J Dent Assoc; 2002; 73(3):12-5, 36. PubMed ID: 12402528
    [No Abstract]   [Full Text] [Related]  

  • 43. Histopathological approach to prostatic contour alterations with the concept of left-right asymmetry.
    Kiyoshima K; Oda Y; Tamiya S; Hori Y; Yamada T; Naito S; Tsuneyoshi M
    Pathol Int; 2006 Jul; 56(7):390-6. PubMed ID: 16792548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostatic carcinoma presenting with painless parotid mass.
    Kirkali Z; Koyuncuoğlu M; Pabuçcuoğlu U; Güneri A; Mungan U
    Urology; 1995 Sep; 46(3):406-7. PubMed ID: 7544935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Left supraclavicular adenopathy. Metastasis of carcinoma of the prostate].
    Avila Padilla J; Capell González M; Centelles Ruiz M; Ardiaca Bosch MC; Badía Torroella F; Abós Fanlo P
    Arch Esp Urol; 1993 May; 46(4):289-93. PubMed ID: 8338368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Metastases to the temporal bone. A report of two cases].
    Grijalba Uche M; Bonaut Mendía JF
    Acta Otorrinolaringol Esp; 1995; 46(6):441-3. PubMed ID: 8554825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serum osteoprotegerin as a novel marker of bone metastasis in prostate cancer].
    Chen HX; Li HZ; Li HJ; Shi BB; Jin W; Cheng XQ
    Zhonghua Wai Ke Za Zhi; 2007 Mar; 45(6):412-4. PubMed ID: 17537330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.
    Hamdy FC; Autzen P; Robinson MC; Horne CH; Neal DE; Robson CN
    Cancer Res; 1997 Oct; 57(19):4427-31. PubMed ID: 9331107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Initial therapy of advanced prostate cancer.
    Ismail M; Gomella LG
    Compr Ther; 1997 Oct; 23(10):649-55. PubMed ID: 9327180
    [No Abstract]   [Full Text] [Related]  

  • 50. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
    Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
    Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone metastases from prostate cancer without elevated prostate-specific antigen levels: diagnosis by anti-PSA immunostaining.
    Berthelot JM; Gouin F; Denis M; Nomballais MF; Maugars Y; Blaive-Cervi S; Prost A
    Rev Rhum Engl Ed; 1995 Jan; 62(1):54-5. PubMed ID: 7540487
    [No Abstract]   [Full Text] [Related]  

  • 52. Prostatic cancer: prognostic criteria.
    Chisholm GD
    Turk J Pediatr; 1984; 26(1-4):265-6. PubMed ID: 6399422
    [No Abstract]   [Full Text] [Related]  

  • 53. [Occult adenocarcinoma of the prostate and supraclavicular adenopathies].
    Solá C; Paredes A; Orube A; Piera JM
    Med Clin (Barc); 1989 Sep; 93(8):317-8. PubMed ID: 2607839
    [No Abstract]   [Full Text] [Related]  

  • 54. [Intraductal adenocarcinoma of the prostate].
    Rabut B; Comoz F; Hurel JP; Bidaud Y; Cante P; Bensadoun H
    Prog Urol; 2001 Jun; 11(3):538-41. PubMed ID: 11512473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Metastasis to the testis and epididymis of a prostatic carcinoma: apropos of a case].
    Guajardo Guajardo J; Aguilo Lucia F; Serrallach Mila N; Bernat Landoni R
    Actas Urol Esp; 1984; 8(3):235-6. PubMed ID: 6475619
    [No Abstract]   [Full Text] [Related]  

  • 56. Prostatic cancer: the case for surveillance.
    Smith PH
    Turk J Pediatr; 1984; 26(1-4):267-72. PubMed ID: 6537079
    [No Abstract]   [Full Text] [Related]  

  • 57. Carcinoma of the prostate. Staging and evaluation procedures.
    Iversen P
    Scand J Urol Nephrol Suppl; 1991; 139():19-24. PubMed ID: 1767268
    [No Abstract]   [Full Text] [Related]  

  • 58. Prostatic adenocarcinoma infiltrating intraprostatic adipose tissue.
    Pan CC
    Hum Pathol; 2011 May; 42(5):759. PubMed ID: 21492748
    [No Abstract]   [Full Text] [Related]  

  • 59. [Morphology and morphogenesis of prostatic small cell cancer].
    Heine M; Lessmeister E
    Pathologe; 1985 Nov; 6(6):323-6. PubMed ID: 3003724
    [No Abstract]   [Full Text] [Related]  

  • 60. [Left supraclavicular adenopathy as a symptom of prostatic adenocarcinoma].
    Ziad F; Serrano Heranz R; Lacasa Marzo J; Aznar Muñoz R
    Actas Urol Esp; 1990; 14(3):243. PubMed ID: 2239408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.